Co-Diagnostics Sets 1-for-25 Reverse Stock Split, Effective Nov. 24

Shares will begin trading split-adjusted on the Nasdaq Capital Market when the market opens Tuesday, Nov. 24, and the ticker stays CODX.

Doctor making a test kit for viral disease COVID-19 nCoV. Laboratory card kit test for coronavirus. COVID-19 rapid test
Photo: Fast Speeds Imagery/Shutterstock.com

Key terms

  • 1-for-25 reverse split effective 12:01 a.m. MT, Tuesday, Nov. 24
  • Split-adjusted trading on Nasdaq Capital Market from Nov. 24; ticker stays CODX
  • About 521,779 shares after the split, down from 13,044,465; new CUSIP 189763 303
  • No fractional shares; holders receive one whole share instead

Co-Diagnostics (Nasdaq: CODX) will carry out a 1-for-25 reverse stock split effective 12:01 a.m. Mountain Time on Tuesday, Nov. 24, the company said in an 8-K filed Thursday, Nov. 19.

Under the split, every 25 shares of common stock will be combined into one share with a par value of $0.001. The shares will begin trading on a split-adjusted basis on The Nasdaq Capital Market when the market opens Nov. 24. The ticker remains CODX.

Share count and fractional shares

The company had 13,044,465 shares of common stock outstanding before the split and expects about 521,779 shares to be outstanding immediately after it takes effect. No fractional shares will be issued. Instead, a stockholder who would otherwise receive a fraction of a share will receive one whole share. The filing does not describe a cash payment for fractions.

Why the company is doing it

The company said the split is intended to help it maintain compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. It also said the split will keep enough authorized shares available for equity financings. The last close before the filing was $0.16 on Nov. 19.

Stockholders approved the split authority at a special meeting on Nov. 13, allowing one or more reverse splits at a ratio of not less than 1-for-2, with a cumulative maximum of 1-for-750. The board approved the 1-for-25 ratio the same day. Articles of Amendment were filed with the Utah Division of Corporations and Commercial Code on Nov. 19.

The common stock will trade under a new CUSIP number, 189763 303, effective Nov. 24. Options and warrants outstanding before the split will be adjusted proportionally under their terms. VStock Transfer, LLC is the exchange agent. Positions held through banks or brokers will be adjusted automatically, and the filing says those holders will not need to take further action, subject to their broker's processes.

Sources

Written with AI from the company's SEC filing and our market data, and checked against those sources before publishing. Our editorial standards.

CODX page →

Filings, figures and price history are on the Co-Diagnostics page.